Aileron Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aileron Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2018 to Q3 2024.
  • Aileron Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 373 %, a 48.4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 373 -350 -48.4% Sep 30, 2024
Q2 2024 433 -234 -35.1% Jun 30, 2024
Q1 2024 492 -132 -21.1% Mar 31, 2024
Q4 2023 616 -95.7 -13.5% Dec 31, 2023
Q3 2023 723 -88.1 -10.9% Sep 30, 2023
Q2 2023 666 -293 -30.5% Jun 30, 2023
Q1 2023 624 -535 -46.2% Mar 31, 2023
Q4 2022 711 -672 -48.6% Dec 31, 2022
Q3 2022 811 -419 -34.1% Sep 30, 2022
Q2 2022 959 +12.1 +1.28% Jun 30, 2022
Q1 2022 1.16K +484 +71.6% Mar 31, 2022
Q4 2021 1.38K +1.06K +327% Dec 31, 2021
Q3 2021 1.23K +920 +296% Sep 30, 2021
Q2 2021 947 +607 +178% Jun 30, 2021
Q1 2021 676 +288 +74.3% Mar 31, 2021
Q4 2020 324 -93.7 -22.4% Dec 31, 2020
Q3 2020 311 -126 -28.8% Sep 30, 2020
Q2 2020 340 -99 -22.5% Jun 30, 2020
Q1 2020 388 -53 -12% Mar 31, 2020
Q4 2019 417 -146 -25.9% Dec 31, 2019
Q3 2019 437 -268 -38% Sep 30, 2019
Q2 2019 439 -467 -51.5% Jun 30, 2019
Q1 2019 441 -381 -46.4% Mar 31, 2019
Q4 2018 563 Dec 31, 2018
Q3 2018 704 Sep 30, 2018
Q2 2018 907 Jun 30, 2018
Q1 2018 822 Mar 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.